Boardroom Alpha
Boardroom Alpha
USB · Current Report (Form 8-K) · Filed April 23, 2026

US Bancorp — Current Report (Form 8-K)

Form
8-K
Filed
April 23, 2026
Period
Apr 21, 2026
Ticker
USB
Accession
0001193125-26-173818
Boardroom Alpha · Filing insights

Shareholders elected 12 directors for 1-year terms; approved executive compensation; ratified Ernst & Young as auditor.

About US Bancorp
Market cap
$84.8B
1Y TSR
+28.7%
3Y TSR
+24.5%
Board grade
C+
Sector
Financial Services
CEO
Gunjan Kedia
Last annual meeting: Apr 21, 2026 · View full US Bancorp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: April 21, 2026

(Date of earliest event reported)

 

 

U.S. BANCORP

(Exact name of registrant as specified in its charter)

 

 

Delaware

(State or other jurisdiction of incorporation)

 

1-6880   41-0255900

(Commission

file number)

 

(IRS Employer

Identification No.)

800 Nicollet Mall

Minneapolis, Minnesota 55402

(Address of principal executive offices, including zip code)

(651) 466-3000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
symbol

 

Name of each exchange
on which registered

Common Stock, $.01 par value per share   USB   New York Stock Exchange
Depositary Shares (each representing 1/100th interest in a share of Series A Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrA   New York Stock Exchange
Depositary Shares (each representing 1/1,000th interest in a share of Series B Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrH   New York Stock Exchange
Depositary Shares (each representing 1/1,000th interest in a share of Series K Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrP   New York Stock Exchange
Depositary Shares (each representing 1/1,000th interest in a share of Series L Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrQ   New York Stock Exchange
Depositary Shares (each representing 1/1,000th interest in a share of Series M Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrR   New York Stock Exchange
Depositary Shares (each representing 1/1,000th interest in a share of Series O Non-Cumulative Perpetual Preferred Stock, par value $1.00)   USB PrS   New York Stock Exchange
Floating Rate Notes, Series CC (Senior), due May 21, 2028   USB/28   New York Stock Exchange
4.009% Fixed-to-Floating Rate Notes, Series CC (Senior), due May 21, 2032   USB/32   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 
 


Item 5.07

Submission of Matters to a Vote of Security Holders.

U.S. Bancorp (the “Company”) held its 2026 annual meeting of shareholders on Tuesday, April 21, 2026. Shareholders considered three proposals at the meeting, each of which is described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March 10, 2026 (the “Proxy Statement”). The final voting results are reported below.

Proposal 1: Election of twelve directors to serve for a one-year term until the 2027 annual meeting of shareholders.

The Company’s shareholders elected each of the twelve nominees for director, and the voting results are set forth below:

 

Name

   For      Against      Abstentions      Broker
Non-Votes
 

Warner L. Baxter

     1,199,626,133        21,517,655        2,197,933        152,923,925  

Dorothy Bridges

     1,213,364,221        8,033,467        1,944,033        152,923,925  

Elizabeth L. Buse

     1,210,462,793        10,836,830        2,042,098        152,923,925  

Alan B. Colberg

     1,207,785,236        13,351,027        2,205,458        152,923,925  

Kimberly N. Ellison-Taylor

     1,212,538,712        8,835,365        1,967,644        152,923,925  

Aleem Gillani

     1,213,417,785        7,747,451        2,176,485        152,923,925  

Roland A. Hernandez

     1,097,316,400        123,851,769        2,173,552        152,923,925  

Gunjan Kedia

     1,159,332,384        61,762,954        2,246,383        152,923,925  

Richard P. McKenney

     1,126,963,724        93,089,497        3,288,500        152,923,925  

Yusuf I. Mehdi

     1,213,222,529        7,754,830        2,364,362        152,923,925  

Loretta E. Reynolds

     1,214,190,913        7,166,929        1,983,879        152,923,925  

John P. Wiehoff

     1,207,347,534        13,840,154        2,154,033        152,923,925  

Proposal 2: Advisory vote to approve the compensation of the Company’s executive officers disclosed in the Proxy Statement.

The Company’s shareholders gave advisory approval of the compensation of the Company’s executive officers disclosed in the Proxy Statement, and the voting results are set forth below:

 

For

 

Against

 

Abstentions

 

Broker Non-Votes

1,138,199,345   79,171,164   5,971,212   152,923,925

Proposal 3: Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year.

The Company’s shareholders ratified the selection of Ernst & Young LLP, and the voting results are set forth below:

 

For

 

Against

 

Abstentions

 

Broker Non-Votes

1,314,933,791   58,312,267   3,019,588  

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

U.S. BANCORP
By:  

/s/ James L. Chosy

  James L. Chosy
  Senior Executive Vice President and General Counsel

Date: April 23, 2026

 

3

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from US Bancorp (USB)

Reference

Frequently asked questions

When did US Bancorp file this 8-K?
US Bancorp (USB) filed this Current Report (Form 8-K) with the SEC on April 23, 2026. The accession number assigned by EDGAR is 0001193125-26-173818.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders elected 12 directors for 1-year terms; approved executive compensation; ratified Ernst & Young as auditor. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find US Bancorp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K US Bancorp has filed under CIK 36104, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer